Atorvastatin Calcium
Product Images NDC 68071-2342

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2342 3)

Packaging label for Atorvastatin Calcium 40mg tablets by NuCare Pharmaceuticals, Inc. The label indicates a quantity of 30 round white film-coated tablets debossed with "40" on one side. It includes the NDC 68071-2342-3, product number P1916030, and states Rx Only. Storage instructions specify controlled temperature 68-77°F. The label also displays lot, expiration date, serial numbers, and a warning to keep out of reach of children.*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Tablets 1)

Chemical structure of Atorvastatin Calcium showing its molecular arrangement, including aromatic rings, hydroxyl groups, and calcium coordination with water molecules.*

FDA Label Image

Figure 1 (Atorvastatin Calcium Tablets 2)

A line graph showing cumulative incidence (%) over time (years) comparing Atorvastatin and placebo groups. The Atorvastatin group is represented by a solid line and the placebo group by a dashed line. The graph indicates lower cumulative incidence in the Atorvastatin group over approximately 3.5 years, with associated hazard ratio and significance values noted on the graph.*

FDA Label Image

Figure 2 (Atorvastatin Calcium Tablets 3)

A line graph depicting cumulative hazard (%) over time (years) to first primary endpoint through four years of follow-up comparing Atorvastatin and placebo treatments. The plot shows lower cumulative hazard for Atorvastatin versus placebo, with a hazard ratio (HR) of 0.63 and p-value of 0.001 indicated on the graph.*

FDA Label Image

Figure 3 (Atorvastatin Calcium Tablets 4)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time (up to 5 years) between Atorvastatin 10 mg and Atorvastatin 80 mg doses. The x-axis represents years to the first major cardiovascular endpoint, and the y-axis shows the percentage of subjects. The graph includes hazard ratio (HR) and p-value data for the comparison.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.